Description: Safe Orthopaedics SA, a medical technology company, develops and markets sterile implants and single-use instruments for the treatment of spinal fracture pathologies in France and internationally. The company offers SteriSpine PS, an all-round kit for the treatment of spinal fractures and degenerative pathologies; and SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems. It also provides SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. The company was founded in 2010 and is headquartered in Éragny-sur-Oise, France.
Home Page: www.safeorthopaedics.com
Parc des Bellevues
Eragny-sur-Oise,
95610
France
Phone:
33 1 34 21 50 00
Officers
| Name | Title |
|---|---|
| Mr. Pierre Dumouchel | Co-Founder, CEO & Chairman |
| Mr. Thomas Droulout | Co-Founder, CTO & Director |
| Mr. Francois-Henri Reynaud | Chief Financial and Admin. Officer & Director |
| Adam Ross | Director of Marketing |
| Ms. Nathalie Vazquez | HR Director |
| Mr. Jochen Esser | Head of Sales for Germany |
| Mr. Nikolaus Beyer | Chief Commercial Officer |
Exchange: PA
Country: FR
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.4024 |
| Price-to-Sales TTM: | 0.0138 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 136 |